A human-specific switch of alternatively spliced AFMID isoforms contributes to TP53 mutations and tumor recurrence in hepatocellular carcinoma
-
Published in Advance
February 15, 2018,
doi:
10.1101/gr.227181.117
Genome Res.
March 2018
vol. 28
no. 3
275-284